Last reviewed · How we verify
Human insulin isophane suspension
Human insulin isophane suspension is a Small molecule drug developed by Eli Lilly and Company. It is currently FDA-approved.
At a glance
| Generic name | Human insulin isophane suspension |
|---|---|
| Sponsor | Eli Lilly and Company |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin (PHASE4)
- Comparison of Two Biphasic Insulin Regimens (NA)
- Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method (NA)
- Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30 (PHASE1)
- Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N (PHASE1)
- Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III (PHASE1)
- A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus (PHASE4)
- Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Human insulin isophane suspension CI brief — competitive landscape report
- Human insulin isophane suspension updates RSS · CI watch RSS
- Eli Lilly and Company portfolio CI
Frequently asked questions about Human insulin isophane suspension
What is Human insulin isophane suspension?
Human insulin isophane suspension is a Small molecule drug developed by Eli Lilly and Company.
Who makes Human insulin isophane suspension?
Human insulin isophane suspension is developed and marketed by Eli Lilly and Company (see full Eli Lilly and Company pipeline at /company/eli-lilly).
What development phase is Human insulin isophane suspension in?
Human insulin isophane suspension is FDA-approved (marketed).